Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies

Human Gene Therapy

Volumn 20, Issue 8, 2009, Pages 796-806

  Clément, Nathalie ^a   Knop, David R ^b   Byrne, Barry J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; STRUCTURAL PROTEIN; VACCINE; VIRUS DNA; VIRUS PROTEIN;

AMPLICON; BACULOVIRUS; BIOREACTOR; CELL SELECTION; CELL STRAIN BHK; GENE TARGETING; GENE THERAPY; GOOD MANUFACTURING PRACTICE; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; INSECT CELL; LARGE SCALE PRODUCTION; NONHUMAN; OPEN READING FRAME; REVIEW; SEROTYPE; VERO CELL;

CLINICAL TRIALS AS TOPIC; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HERPESVIRIDAE; HUMANS; SEROTYPING;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 68949210394     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.094     Document Type: Review

References (67)

1. Aslanidi, G., Lamb, K., and Zolotukhin, S. (2009). An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells. Proc. Natl. Acad. Sci. U.S.A. 106, 5059-5064.
2. Aucoin, M.G., Perrier, M., and Kamen, A.A. (2008). Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol. Adv. 26, 73-88.
3. Blankinship, M.J., Gregorevic, P., and Chamberlain, J.S. (2006). Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors. Mol. Ther. 13, 241-249.
4. Blits, B., and Bunge, M.B. (2006). Direct gene therapy for repair of the spinal cord. J. Neurotrauma 23, 508-520.
5. Bloch, J., Bachoud-Levi, A.C., Deglon, N., Lefaucheur, J.P., Winkel, L., Palfi, S., Nguyen, J.P., Bourdet, C., Gaura, V., Remy, P., Brugieres, P., Boisse, M.F., Baudic, S., Cesaro, P., Hantraye, P., Aebischer, P., and Peschanski, M. (2004). Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study. Hum. Gene Ther. 15, 968-975.
6. Boedeker, B.G. (2001). Production processes of licensed recombinant factor VIII preparations. Semin. Thromb. Hemost. 27, 385-394.
7. Booth, M.J., Mistry, A., Li, X., Thrasher, A., and Coffin, R.S. (2004). Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids. Gene Ther. 11, 829-837.
8. Buller, R.M., Janik, J.E., Sebring, E.D., and Rose, J.A. (1981). Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J. Virol. 40, 241-247.
9. Burton, E.A., Fink, D.J., and Glorioso, J.C. (2005). Replication- defective genomic HSV gene therapy vectors: Design, production and CNS applications. Curr. Opin. Mol. Ther. 7, 326-336.
10. Cecchini, S., Negrete, A., and Kotin, R.M. (2008). Toward exascale production of recombinant adeno-associated virus for gene transfer applications. Gene Ther. 15, 823-830.
11. Cecchini, S., Virag, T., Negrete, A., and Kotin, R.M. (2009). Production and processing of rAAVU7smOPT in 100 L bioreactors for canine models of Duchenne muscular dystrophy. Mol. Ther. 17, S17.
12. Conway, J.E., Zolotukhin, S., Muzyczka, N., Hayward, G.S., and Byrne, B.J. (1997). Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 71, 8780-8789.
13. Conway, J.E., Rhys, C.M., Zolotukhin, I., Zolotukhin, S., Muzyczka, N., Hayward, G.S., and Byrne, B.J. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther. 6, 986-993.
14. Costantini, L.C., Jacoby, D.R., Wang, S., Fraefel, C., Breakefield, X.O., and Isacson, O. (1999). Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Hum. Gene Ther. 10, 2481-2494.
15. Durocher, Y., Pham, P.L., St-Laurent, G., Jacob, D., Cass, B., Chahal, P., Lau, C.J., Nalbantoglu, J., and Kamen, A. (2007). Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells. J. Virol. Methods 144, 32-40.
16. Epstein, A.L., Marconi, P., Argnani, R., and Manservigi, R. (2005). HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. Curr. Gene Ther. 5, 445-458.
17. Feng, L., Guo, M., Zhang, S., Chu, J., and Zhuang, Y. (2007). Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adeno-associated virus-β-galactosidase reporter gene) production in suspension-cultured HEK-293 (human embryonic kidney 293) cells. Biotechnol. Appl. Biochem. 46, 127-135.
18. Feudner, E., De Alwis, M., Thrasher, A.J., Ali, R.R., and Fauser, S. (2001). Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system. J. Virol. Methods 96, 97-105.
19. Glauser, D.L., Strasser, R., Laimbacher, A.S., Saydam, O., Clement, N., Linden, R.M., Ackermann, M., and Fraefel, C. (2007). Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: Molecular mechanisms of interaction. J. Virol. 81, 4732-4743.
20. Grimm, D., and Kleinschmidt, J.A. (1999). Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use. Hum. Gene Ther. 10, 2445-2450.
21. Handa, H., and Carter, B.J. (1979). Adeno-associated virus DNA replication complexes in herpes simplex virus or adenovirus-infected cells. J. Biol. Chem. 254, 6603-6610.
22. Heilbronn, R., Burkle, A., Stephan, S., and Zur Hausen, H. (1990). The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J. Virol. 64, 3012-3018.
23. Hermonat, P.L., and Muzyczka, N. (1984). Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. U.S.A. 81, 6466-6470.
24. Hibbitt, O.C., and Wade-Martins, R. (2006). Delivery of large genomic DNA inserts >100 kb using HSV-1 amplicons. Curr. Gene Ther. 6, 325-336.
25. Hildinger, M., Baldi, L., Stettler, M., and Wurm, F.M. (2007). High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells. Biotechnol. Lett. 29, 1713-1721.
26. Hwang, K.K., Mandell, T., Kintner, H., Zolotukhin, S., Snyder, R., and Byrne, B.J. (2003). High titer recombinant adeno-associated virus production using replication deficient herpes simplex viruses type 1. Mol. Ther. 7, S14-S15.
27. Johnston, K.M., Jacoby, D., Pechan, P.A., Fraefel, C., Borghesani, P., Schuback, D., Dunn, R.J., Smith, F.I., and Breakefield, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8, 359-370.
28. Kang, W., Wang, L., Harrell, H., Liu, J., Thomas, D.L., Mayfield, T.L., Scotti, M.M., Ye, G.J., Veres, G., and Knop, D.R. (2009). An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes. Gene Ther. 16, 229-239.
29. Knop, D.R., and Harrell, H. (2007). Bioreactor production of recombinant herpes simplex virus vectors. Biotechnol. Prog. 23, 715-721.
30. Kohlbrenner, E., Aslanidi, G., Nash, K., Shklyaev, S., Campbell-Thompson, M., Byrne, B.J., Snyder, R.O., Muzyczka, N., Warrington, K.H., Jr., and Zolotukhin, S. (2005). Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 12, 1217-1225.
31. Kotin, R.M., Linden, R.M., and Berns, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078.
32. Lam, P., Hui, K.M., Wang, Y., Allen, P.D., Louis, D.N., Yuan, C.J., and Breakefield, X.O. (2002). Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors. Hum. Gene Ther. 13, 2147-2159.
33. Liu, Q., Perez, C.F., and Wang, Y. (2006). Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector. J. Virol. 80, 1672-1679.
34. Mah, C., Pacak, C.A., Cresawn, K.O., Deruisseau, L.R., Germain, S., Lewis, M.A., Cloutier, D.A., Fuller, D.D., and Byrne, B.J. (2007). Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors. Mol. Ther. 15, 501-507.
35. Mandel, R.J., Burger, C., and Snyder, R.O. (2008). Viral vectors for in vivo gene transfer in Parkinson's disease: Properties and clinical grade production. Exp. Neurol. 209, 58-71.
36. McLaughlin, S.K., Collis, P., Hermonat, P.L., and Muzyczka, N. (1988). Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62, 1963-1973.
37. Mendelson, E., Trempe, J.P., and Carter, B.J. (1986). Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide. J. Virol. 60, 823-832.
38. Mishra, L., and Rose, J.A. (1990). Adeno-associated virus DNA replication is induced by genes that are essential for HSV-1 DNA synthesis. Virology 179, 632-639.
39. Mueller, C., and Flotte, T.R. (2008a). Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15, 858-863.
40. Mueller, C., and Flotte, T.R. (2008b). Gene therapy for cystic fibrosis. Clin. Rev. Allergy Immunol. 35, 164-178.
41. Negrete, A., Esteban, G., and Kotin, R.M. (2007a). Process optimization of large-scale production of recombinant adeno-associated vectors using dielectric spectroscopy. Appl. Microbiol. Biotechnol. 76, 761-772.
42. Negrete, A., Yang, L.C., Mendez, A.F., Levy, J.R., and Kotin, R.M. (2007b). Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system. J. Gene Med. 9, 938-948.
43. Oehmig, A., Cortes, M.L., Perry, K.F., Sena-Esteves, M., Fraefel, C., and Breakefield, X.O. (2007). Integration of active human β-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector. Gene Ther. 14, 1078-1091.
44. Osten, P., Grinevich, V., and Cetin, A. (2007). Viral vectors: A wide range of choices and high levels of service. Handb. Exp. Pharmacol. 178, 177-202.
45. Ozuer, A., Wechuck, J.B., Goins, W.F., Wolfe, D., Glorioso, J.C., and Ataai, M.M. (2002a). Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnol. Bioeng. 77, 685-692.
46. Ozuer, A., Wechuck, J.B., Russell, B., Wolfe, D., Goins, W.F., Glorioso, J.C., and Ataai, M.M. (2002b). Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnol. Prog. 18, 476-482.
47. Pacak, C.A., Mah, C.S., Thattaliyath, B.D., Conlon, T.J., Lewis, M.A., Cloutier, D.E., Zolotukhin, I., Tarantal, A.F., and Byrne, B.J. (2006). Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3-e9.
48. Park, J.Y., Lim, B.P., Lee, K., Kim, Y.G., and Jo, E.C. (2006). Scalable production of adeno-associated virus type 2 vectors via suspension transfection. Biotechnol. Bioeng. 94, 416-430.
49. Rice, S.A., and Knipe, D.M. (1990). Genetic evidence for two distinct transactivation functions of the herpes simplex virus a protein ICP27. J. Virol. 64, 1704-1715.
50. Samulski, R.J., Chang, L.S., and Shenk, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
51. Sandri-Goldin, R.M. (2008). The many roles of the regulatory protein ICP27 during herpes simplex virus infection. Front. Biosci. 13, 5241-5256.
52. Schleiss, M.R. (2009). Persistent and recurring viral infections: the human herpesviruses. Curr. Probl. Pediatr. Adolesc. Health Care 39, 7-23.
53. Schultz, B.R., and Chamberlain, J.S. (2008). Recombinant adeno-associated virus transduction and integration. Mol. Ther. 16, 1189-1199.
54. Slanina, H., Weger, S., Stow, N.D., Kuhrs, A., and Heilbronn, R. (2006). Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication. J. Virol. 80, 5241-5250.
55. Taddeo, B., Esclatine, A., and Roizman, B. (2004). Post-transcriptional processing of cellular RNAs in herpes simplex virus-infected cells. Biochem. Soc. Trans. 32, 697-701.
56. Thomas, D.L., Wang, L., Niamke, J., Liu, J., Kang, W., Scotti, M.M., Ye, G.J., Veres, G., and Knop, D.R. (2009). Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells. Hum. Gene Ther. doi: 10.1089/hum.2009.004.
57. Trempe, J.P., Mendelson, E., and Carter, B.J. (1987). Characterization of adeno-associated virus Rep proteins in human cells by antibodies raised against Rep expressed in Escherichia coli. Virology 161, 18-28.
58. + hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J. Virol. 76, 7150-7162.
59. Ward, P., Falkenberg, M., Elias, P., Weitzman, M., and Linden, R.M. (2001). Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system. J. Virol. 75, 10250-10258.
60. Warnock, J.N., Merten, O.W., and Al-Rubeai, M. (2006). Cell culture processes for the production of viral vectors for gene therapy purposes. Cytotechnology 50, 141-162.
61. Wechuck, J.B., Ozuer, A., Goins, W.F., Wolfe, D., Oligino, T., Glorioso, J.C., and Ataai, M.M. (2002). Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors. Biotechnol. Bioeng. 79, 112-119.
62. Weindler, F.W., and Heilbronn, R. (1991). A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J. Virol. 65, 2476-2483.
63. Wustner, J.T., Arnold, S., Lock, M., Richardson, J.C., Himes, V.B., Kurtzman, G., and Peluso, R.W. (2002). Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap. Mol. Ther. 6, 510-518.
64. Zecchini, T.A., and Smith, R.J. (1999). Production of high titre disabled infectious single cycle (DISC) HSV from a microcarrier culture. Cytotechnology 30, 203-210.
65. Zhang, X., De Alwis, M., Hart, S.L., Fitzke, F.W., Inglis, S.C., Boursnell, M.E., Levinsky, R.J., Kinnon, C., Ali, R.R., and Thrasher, A.J. (1999). High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Hum. Gene Ther. 10, 2527-2537.
66. Zolotukhin, S., Byrne, B.J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R.J., and Muzyczka, N. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985.
67. Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T.J., JR., Chiodo, V.A., Phillipsberg, T., Muzyczka, N., Hauswirth, W.W., Flotte, T.R., Byrne, B.J., and Snyder, R.O. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28, 158-167.